Introduction {#S1}
============

Clinical treatment of carbapenem-resistant *Enterobacteriaceae* (CRE) is a critical challenge ([@B14]). Carbapenemase, which can be found as serine proteases and metalloproteinases, is responsible for carbapenem resistance. New Delhi metallo-β-lactamase (NDM) is a metallo-β-lactamase able to hydrolyze carbapenem ([@B12]). Although NDM-producing CRE has increased globally recently, the worldwide distribution and prevalence of NDM-positive strains appear to be variable between different countries and regions ([@B9]; [@B12]; [@B13]; [@B26]; [@B18]; [@B27]). NDM-producing CRE strains have mainly spread in South Asia, the Baltans, North Africa and the Middle East ([@B7]; [@B27]). Chinese national surveillance of carbapenem-resistant CRE in China has shown that NDM-producing CRE are less common than KPC-producing CRE, and NDM-positive strains are mainly *E. coli* ([@B30], [@B31]; [@B26]).

Since the first report of NDM in 2009, many variant NDMs have emerged ([@B29]; [@B7]; [@B12]; [@B27]). Compared with NDM-1, NDM-7 has only two different amino acids, including Asp130Asn and Met154Leu, and NDM-7 has more enzymatic hydrolysis activity against carbapenem ([@B6]; [@B19]). NDM-7 mainly exists in the IncX3-type plasmid and disseminates among different isolates ([@B3]). In this study, we analyzed the genomic sequence of the NDM-7-producing ST34 *K. pneumoniae* strain and the genetic surroundings and molecular characterization of NDM-7.

Materials and Methods {#S2}
=====================

Patient and Bacterial Strain {#S2.SS1}
----------------------------

Carbapenem-resistant *K. pneumoniae* was isolated from a bile sample collected from a young woman in Hangzhou First People's Hospital in March 2017. The strain was identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF-MS, Bruker MALDI-TOF Microflex LT/SH, Bruker Diagnostics, Germany) according to the manufacturer's instructions. The patient had no history of traveling abroad. Informed consent was obtained for this study. The methods in this study were approved by the institutional ethics committee of Hangzhou First People's Hospital and were carried out in accordance with the approval guidelines.

Antimicrobial Susceptibility Testing and Detection of Carbapenemase {#S2.SS2}
-------------------------------------------------------------------

Antimicrobial susceptibility was determined by the VITEK compact II automated microbiology system and interpreted according to the Clinical and Laboratory Standards Institute guidelines in 2018 (CLSI). The modified carbapenemase inactivation method (mCIM) and EDTA-modified mCIM (eCIM) were used to detect carbapenemase and metallo-β-lactamase as recommended by the CLSI in 2018 ([@B5]).

Detection of Carbapenemase Genes {#S2.SS3}
--------------------------------

PCR was performed to screen carbapenem resistance genes, including *bla*~*KPC*~, *bla*~IMP~, *bla*~*VIM*~, *bla*~NDM~, and *bla*~*OXA--*48~. The amplicons were sequenced by Sanger sequencing.

Conjugation and Transformation Experiments {#S2.SS4}
------------------------------------------

To evaluate the horizontal transferability of *bla*~NDM~, mixed broth mating was used as described in a previous study ([@B8]). Sodium azide-resistant *E. coli J53* was used as the recipient strain (donated by Professor YU, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University). The transconjugants were selected on MacConkey agar containing 100 mg/liter sodium azide and 2 mg/liter meropenem for 24 h at 37°C. The electrotransformation assay was also performed to evaluate the dissemination of *bla*~NDM~ using *DH5*α as the recipient strain as in a previous study ([@B9]). The presumptive transconjugants were selected on MH agar plates supplemented with 2 mg/liter meropenem. All successful transformants were confirmed for the presence of *bla*~NDM~ by PCR, and an antimicrobial susceptibility test was performed using the *E*-test method in parallel with the original strains and donor strains.

Whole Genome Sequencing {#S2.SS5}
-----------------------

The DNA of HZW25 was extracted according to the manufacturer's instructions and sequenced with Pacific Biosciences RSII SMRT technology SMRT technology (Menlo Park, CA, United States). Sequence reads were assembled using a hierarchical genome assembly process (HGAP) compiled specifically for quality trimming and *de novo* assembly. The graphical maps of the whole genome were converted by BLAST Ring Image Generator (BRIG). The whole-genome sequence was annotated using the Prokaryotic Genomes Automatic Annotation Pipeline (PGAAP) server available at NCBI.^[1](#footnote1){ref-type="fn"}^ Multilocus sequence typing (MLST) analysis of HZW25 and cgMLST phylogenetic relationship analysis of all public sequences of ST34 were performed using the BacWGSTdb server with the entire genome sequence ([@B20]). The antibiotic resistance genes were determined using ResFinder 3.0 with \> 97% gene identity threshold (exception of β-lactamase variants with 100% identity) and 100% gene length and the comprehensive antibiotic resistance database (CARD) at <https://card.mcmaster.ca/> with resistance gene identifier of \> 90% identity. The virulence factors were detected using the virulence database of *K. pneumoniae*^[2](#footnote2){ref-type="fn"}^ and a virulence factor database.^[3](#footnote3){ref-type="fn"}^

Plasmid Analysis {#S2.SS6}
----------------

All plasmid sequences were annotated using the PGAAP server. The plasmid replicon type was determined by PlasmidFinder^[4](#footnote4){ref-type="fn"}^ with a 95% threshold for identity and 100% coverage. The *bla*~NDM--7~-carrying plasmid was compared to the publicly available plasmid references using BLAST at GenBank ([www.ncbi.nlm.nih.gov/GenBank/](http://www.ncbi.nlm.nih.gov/GenBank/)). The plasmid comparisons were generated by Easyfig according to the online protocol,^[5](#footnote5){ref-type="fn"}^ and presentations were generated by EdrawMax. The genetic environment of *bla*~NDM--7~ was analyzed and compared that of *bla*~NDM~ variants.

Nucleotide Sequence Accession Number {#S2.SS7}
------------------------------------

The complete nucleotide sequence of HZW25 and four plasmids were deposited under the GenBank accession numbers [CP025211](CP025211)--[CP025215](CP025215).

Results {#S3}
=======

Susceptibility Test {#S3.SS1}
-------------------

HZW25 was resistant to all β*-*lactams tested, while it was susceptible to aminoglycosides and fluoroquinolones. Carbapenemase activity was positive with mCIM and eCIM tests, suggesting the production of metallo-β-lactamase (MBL).

Antimicrobial Resistance Genes and Transfer Experiments {#S3.SS2}
-------------------------------------------------------

The acquired antibiotic resistance genes, including *bla*~NDM--7~, *bla*~SHV--26~, *fosA*, *oqxA*, and *oqxB*, were responsible for the resistance profile of HZW25. In addition, intrinsic antibiotic resistance genes with CARD resistance gene identifiers were also identified, including antibiotic efflux pumps of the major facilitator superfamily (MFS) (KpnE, KpnF, KpnG, KpnH, and ermR), an ATP-binding cassette (ABC) antibiotic efflux pump (msbA), regulators of the efflux pump (marA and marR), the porin membrane protein OmpK35 and a bleomycin resistance gene (BRP). There were no mutations in resistance genes on the chromosome. Only *bla*~NDM--7~ was located on the plasmid, while the other resistance genes were located on the chromosome. *bla*~NDM--7~ was successfully transferred to *E. coli AzR J53* by conjugation and to *E. coli DH5*α by electroporation, and the transconjugants displayed resistance to broad-spectrum cephalosporins and carbapenems ([Table 1](#T1){ref-type="table"}). The presence of the *bla*~NDM--7~ gene in transconjugants was confirmed by PCR.

###### 

The minimum inhibitory concentration to antibiotics of transformed isolates with *E*-test methods (ug/mL).

                CRO       AMC     CTX       FEP       SCF       MEM       IPM     CIP       LEV     MH      ATM       TM     CN
  ------------- --------- ------- --------- --------- --------- --------- ------- --------- ------- ------- --------- ------ ------
  HZW25:J53     \>256     \>256   \>256     \>256     \>256     \>32      \>32    0.008     0.023   1       0.064     0.25   0.25
  J53           \<0.064   4       \<0.064   \<0.064   \<0.064   \<0.008   0.5     \<0.008   0.023   1       0.064     0.25   0.25
  DH5a:pHZW25   \>256     \>256   \>256     \>256     256       32        \>32    0.008     0.023   0.5     0.064     0.25   0.25
  DH5a          \<0.064   2       \<0.064   \<0.064   \<0.064   \<0.008   0.008   \<0.008   0.023   0.5     \<0.064   0.25   0.25
  HZW25         \>256     \>256   \>256     \>256     \>256     \>32      \>32    0.25      0.75    \>256   0.5       0.25   0.25

CRO, Ceftriaxone; AMC, Amoxicillin-clavulanic acid; CTX, Cefotaxime; FEP, Cefepime; SCF, Sulbactam and Cefoperazone; MEM, Meropenem; IPM, Imipenem; CIP, Ciprofloxacin; LEV, Levofloxacin; MH, Minocycline; ATM, Aztreonam; TM, Tobramycin; CN, Gentamicin.

Molecular Grouping and Whole Genome Sequencing {#S3.SS3}
----------------------------------------------

Approximately 1.2 Gb clean data was generated after whole genome sequencing with Pacific Biosciences RSII SMRT technology, providing a 221.0-fold average coverage of the genome. The data were assembled into five contigs, which contained one chromosome and four plasmids ([Figure 1](#F1){ref-type="fig"}). HZW25 belonged to ST34 with the MLST sequence 2-3-6-1-9-7-4. The isolate was negative for the string test due to the deficiency of the *rmpA* and *rmpA2* genes. HZW25 belonged to the K73 capsular type as determined by the *wzi* gene encoding the outer membrane protein of the cluster. Virulence genes were present in HZW25, including the *mrkABCDFHIJ* operon encoding type 3 fimbriae for biofilm formation, the *fimABCDEFGHIK* operon encoding type 1 fimbriae for adherence, the *iutA* gene encoding aerobactin, the *entABCDEFS* operon and the *fepABCDG* operon encoding enterobactin siderophore, and the *iroE* and *iroN* genes encoding salmochelin. HZW25 also had a secretion system including the *clpV* gene encoding T6SS-II, *dotU*, the *impAFGHJ* operon, *ompA* and *sciN* encoding T6SS-III. The four plasmids were designated P1, P2, P3 and P4, and they belonged to IncFIB(K), IncR, IncFII(pKPX1), and IncX3, respectively. The plasmids were characterized, and the results are shown in [Table 2](#T2){ref-type="table"}. Only P4 carried a resistance gene with *bla*~NDM--7~, and the other plasmids harbored no resistance genes. To date, there have been 57 *K. pneumoniae* strains belonging to ST34 worldwide, including Japan (*n* = 31), the United States (*n* = 10), China (*n* = 2), the United Kingdom (*n* = 2) and other countries (*n* = 12). Almost all strains were collected from humans and carried the *bla*~SHV--26~, *fosA*, *oqxA*, and *oqxB* resistance genes, but only HZW25 had *bla*~NDM~ variants of *bla*~NDM--7~. Thirty-one strains from Japan carried *bla*~IMP--1~ and *bla*~CTX--M--2~ in addition to *bla*~SHV--26~ ([Supplementary 1](#TS1){ref-type="supplementary-material"}). All chromosomes of the ST34 *K. pneumoniae* strains harbored virulence clusters, such as the type I fimbriae cluster *fim* operon, type III fimbriae cluster *mrk* operon, and enterobactin siderophore cluster *fep* and *ent* operon ([Supplementary 1](#TS1){ref-type="supplementary-material"}). The phylogenetic trees of all ST34 *K. pneumoniae* strains in GenBank revealed that HZW25 was in a separate cluster ([Figure 2](#F2){ref-type="fig"}), suggesting that the HZW25 strain had a long evolutionary distance from the others.

![The complete genome of *K. pneumoniae* strain HZW25.](fmicb-11-01885-g001){#F1}

###### 

The genomic information of HZW25 and four plasmids.

          Genome length   Number of genes   Plasmid type    Resistant genes            Accession number
  ------- --------------- ----------------- --------------- -------------------------- ----------------------
  HZW25   5 198 587       5 776             --              SHV-26, oqxA, oqxB, fosA   [CP025211](CP025211)
  P1      145 759         174               IncFIB(K)       --                         [CP025212](CP025212)
  P2      103 957         112               IncR            --                         [CP025213](CP025213)
  P3      87 395          123               IncFII(pKPX1)   --                         [CP025214](CP025214)
  P4      68 637          93                IncX3           NDM-7                      [CP025215](CP025215)

![The phylogenetic trees of all ST34 *K. pneumoniae* strains of released public sequences. The evolutionary distance showed that HZW25 was far from the other strains.](fmicb-11-01885-g002){#F2}

Characterization and Genetic Context of the *bla*~NDM--7~ Gene {#S3.SS4}
--------------------------------------------------------------

The *bla*~NDM--7~ gene was localized in plasmid P4 and could be horizontally transferred successfully from the donor strain HZW25 to the recipient strains *E. coli J53* and *E. coli DH5*α. P4 was 68 637 bp in size with a G + C content of 45.69% and 93 open reading frames. Comparative DNA sequence analysis showed that P4 possessed an IncX3-type backbone. A comparison of the whole region between *P4, pEC25_NMD-7, pNDM5_020001*, and *pEh1A* showed that the genetic context of the regions flanking the NDM variants was similar, and the backbone of plasmids showed high degrees of conversation and similarity. The NDM variant transposable elements of *P4*, *pEC25_NMD-7* and *pNDM5_020001* were highly similar with the *ISL3* family and *IS3000* transposons. Δ*ISAba125* was upstream of the *bla*~NDM~ variants and was inserted by the *IS5* or Δ*IS5* sequence ([Figure 3](#F3){ref-type="fig"}).

![The comparative genetic context of *bla*~NDM~ variants between *P4*, *pEC25_NMD-7, pNDM5_020001*, and *pEH1A.*](fmicb-11-01885-g003){#F3}

Discussion {#S4}
==========

Carbapenemase-resistant *K. pneumoniae* (CRKP) has been a significant clinical problem with very limited therapeutic options ([@B14]). Due to the high-level resistance of CRKP to almost all antibiotics and the high mortality rate of CRKP infections, carbapenemase-producing carbapenem resistance is a public health threat ([@B14]; [@B31]).

In China, CRE strains are mainly composed of KPC-producing *K. pneumoniae* and NDM-producing *E. coli* ([@B30], [@B31]). NDM-7 has been reported in *E. coli* strains ([@B10]). Recently, NDM-7 carrying the IncA/C2 type plasmid harbored by *K. pneumoniae* strain ST147 was reported ([@B22]). In our study, *bla*~NDM--7~ was first reported in ST34 *K. pneumoniae*. HZW25 was isolated from a young woman with acute cholangitis infection; based on multilocus sequence typing, HZW25 belongs to ST34 and contains several resistance genes responsible for beta-lactam resistance. The *bla*~NDM--7~ gene was located on an IncX3 plasmid, and the genetic environments and characteristics of the *bla*~NDM--7~-producing plasmid P4 were analyzed. The module of NDM-7 transposable elements was highly similar to the *bla*~NDM~ variants harboring the IncX3-type plasmid, suggesting that this NDM variant module could disseminate among different clones.

In recent years, NDM variants, including NDM-7, have been increasingly reported in CRE isolates ([@B12]; [@B27]). In contrast to foreign countries, such as India, Spain and Canada, where NDM-7-producing strains are mainly *K. pneumoniae* strains ([@B3]; [@B21]; [@B16]; [@B13]), in China, NDM variants are more common in carbapenemase-producing *E. coli* ([@B1]; [@B26]; [@B31]). Wang L reported NDM-7-producing uropathogenic *E. coli* from a patient with bacteriuria in 2016 ([@B25]). Bi R reported a high prevalence of *bla*~NDM~ variants in CRE *E. coli* strains, and *bla*~NDM--7~ ranked third among those variants ([@B1]). Hao Y analyzed the genotypic and phenotypic characterization of *bla*~NDM--7~ in *E. coli* from a patient with a urinary tract infection ([@B10]). Recently, Xu J and He F also reported NDM-7-producing *E. coli* from a urinary sample ([@B28]).

Although *bla*~NDM~ variants are both located on bacterial chromosomes and plasmids, *bla*~NDM~ variants positioned on plasmids play a vital role in the dissemination of resistance genes ([@B2]; [@B11]). *bla*~NDM~ variants harboring plasmids are mainly of the IncFII, IncX3, and IncC(IncA/C2) types ([@B18]). IncX3 is the most common type of plasmid carrying *bla*~NDM~, and most IncX3 plasmids are present in *E. coli* ([@B17]; [@B1]). From the worldwide distribution of *bla*~NDM~-carrying plasmids in *Enterobacteriaceae*, IncX3 plasmids may serve as an important vehicle in the dissemination of NDM in East Asia, particularly in China ([@B11]). Hao Y compared the backbones of plasmids carrying NDM variants and collected from human and food animal origin, and the results showed that all plasmids were highly similar (\> 99%) among patients ([@B10]). This suggested that IncX3 plasmids may serve as one of the major platforms on which *bla*~NDM~ genes evolve with the generation of new NDM variants. Lee CS isolated NDM-7-producing *K. pneumoniae* and *E. coli* simultaneously from a patient, suggesting that *bla*~NDM--7~ might be transferred between *K. pneumoniae* and *E. coli in vivo* ([@B15]).

In our study, *bla*~NDM--7~ was in a 68 637 bp IncX3-type plasmid. *bla*~NDM--7~ was successfully transferred to *E. coli AzR J53* by conjugation and to *E. coli DH5a* by electroporation. Compared to the common genetic contexts of *bla*~NDM~ variants, *bla*~NDM--7~ had a similar surrounding environment, with *ISAba125* (intact or truncated) upstream and *ble*~*MBL*~ downstream; these elements are located in the transposon-like structure flanked by *IS3000* and *IS26*, responsible for horizontal transfer of *bla*~NDM--7~ among *Enterobacteriaceae*.

The *bla*~NDM--7~ gene can be carried by different *K. pneumoniae* strains of different STs, including ST147, ST138, ST273, ST437, and ST278 ([@B15]; [@B3]; [@B21]; [@B4]; [@B16]; [@B18]; [@B22]). Although these strains were isolated in different countries and regions, these strains contain plasmids carrying *bla*~NDM--7~ with similar surroundings and are characterized by horizontal gene transmission ([@B3]). Chen described *bla*~NDM~-carrying plasmids from different *Enterobacteriaceae* isolates with identical structures, suggesting that very effective horizontal transfer events had occurred ([@B3]). Seara N reported the interhospital spread of NDM-7-producing *K. pneumoniae* in Spain ([@B21]). In our study, ST34 *K. pneumoniae* carrying *bla*~NDM--7~ was reported for the first time, and the evolutionary distance from known ST34 *K. pneumoniae* strains showed that the strain we isolated was far from the other isolated strains.

Ceftazidime-avibactam is an effective antibiotic for CRE. It has good antibacterial activity against KPC-producing *K. pneumoniae* but not NDM-producing *K. pneumoniae* or *E. coli* ([@B24]; [@B23]). The emergence of NDM-producing *K. pneumoniae* would be troublesome in CRE treatment using ceftazidime-avibactam. Therefore, it is important to screen carbapenemase types before ceftazidime-avibactam therapy, and it is necessary to detect serine proteases and metalloproteinases in epidemiological investigations.

Conclusion {#S5}
==========

This study describes *bla*~NDM--7~ in an ST34 *K. pneumoniae* strain for the first time. The *bla*~NDM--7~ gene is located on a conjugated and horizontally transmitted IncX3-type plasmid. The potential dissemination of *bla*~NDM~-like genes in IncX3-type plasmids should be considered. Before treatment with ceftazidime-avibactam, it is necessary to determine the types of carbapenemase in carbapenemase-resistant *K. pneumoniae.*
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